Ovarian Cancer : Drugs
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
Drugs could include:
-
Platinol (Restricted Access)
 |
Ovarian cancer is cancer of the ovaries, the eggreleasing and hormone-producing organs of the female reproductive tract. Cancerous, or malignant, cells divide and multiply in an abnormal fashion.
|
 |
Ovarian cancer is a disease in which the cells in the ovaries become abnormal, start to grow uncontrollably, and form tumors. Ninety percent of all ovarian cancers A close-up of a cancerous growth on the ovary. ( Illustration by GGS Information Se...
|
|
Doxorubicin is a cancer (antineoplastic) medication. Doxorubicin interferes with the
growth of cancer cells and slows their growth and spread in the body.
|
|
Carboplatin is a chemotherapeutic agent used to treat cancer by interfering with the growth of cancer cells. Carboplatin is marketed under the brand name Paraplatin; it may also be referred to as CBDCA, JM-8, or carboplatinum.
|
|
Antineoplastic agent; platinum-containing compound.
|
|
Carboplatin is an antineoplastic medication. Carboplatin interferes with the growth of cancer
cells and slows their growth and spread in the body.
|
|
Cisplatin, also known by the brand name Platinol-AQ, Cis-platinum, CDDP, or DDP, is a chemotherapy medicine used to treat certain types of cancer by destroying cancerous cells. Purpose Cisplatin is approved by the Food and Drug Administration (FDA) to treat metastatic testicular cancer and metastatic ovarian cancer .
|
|
Antineoplastic agent; platinum-containing compound.
|
|
Cisplatin is an antineoplastic medication. Cisplatin interferes with the growth of cancer cells
and slows their growth and spread in the body.
|
|
Cyclophosphamide is a cancer (chemotherapeutic) medication. Cyclophosphamide interferes
with the growth of cancer cells and slows their growth and spread in the body.
|
|
Antineoplastic agent and immunosuppressant; nitrogen mustard-derivative alkylating agent.
|
|
Cyclophosphamide is an anticancer (antineoplastic) agent. It also acts as a suppressor of the immune system.
|
|
Antineoplastic agent; anthracycline glycoside antibiotic.
|
|
Doxorubicin, which kills cancer cells, is among the most widely used chemotherapy drugs. It is also known by its trade name, Adriamycin.
|
|
Etoposide is a chemotherapy medicine used to treat cancer by destroying cancerous cells. Etoposide is also known as the brand name VePesid.
|
|
Antineoplastic agent; semisynthetic podophyllotoxin-derivative.
|
|
Gemcitabine is a cancer medication that interferes with the growth and spread of cancer
cells in the body.
|
|
Antimetabolite antineoplastic agent; a synthetic pyrimidine nucleoside.
|
|
Gemcitabine is a drug that is used to treat advanced stages of pancreatic, lung, and other cancers. Its brand name is Gemzar.
|
|
Topotecan is a cancer medication that interferes with the growth and spread of cancer
cells in the body.
|
|
Paclitaxel is a cancer medication that interferes with the growth of cancer cells and slows
their growth and spread in the body.
|
|
Paclitaxel is a drug used to treat certain types of cancer. Paclitaxel is available under the trade name Taxol.
|
|
Antineoplastic agent; natural or semisynthetic diterpene from the bark of the Western (Pacific) yew ( Taxus brevifolia ) or needles and twigs of Taxus baccata .
|
|
Etoposide is a cancer medicine that interferes with the growth of cancer cells and slows
their growth and spread in the body.
|
|
Topotecan is a drug used to treat certain types of cancer. Topotecan is available under the trade name Hycamtin, and may also be referred to as topotecan hydrochloride or topotecan HCl.
|
|
Antineoplastic agent; a semisynthetic derivative of camptothecin.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.